A Population Perspective on Ethical Compliance with Drug Trial Standards of Practice

Article type: Research Article

Authors: Wang, Ningsheng^{a; 1} | Zeng, Lingfeng^{a; b; 1} | Zeng, Xing^b | Liu, Jun^b | Liang, Weixiong^{c; *} | Wang, Qi^{a; c; *}

Affiliations: [a] Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, China | [b] Ethics Committee, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China | [c] Drug Clinical Trial Institute, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China

Correspondence: [] Correspondence to: Weixiong Liang, Drug Clinical Trial Institute, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China. Tel.: +86 20 81887233; Fax: +86 20 81874903; E-mail: [email protected] and Qi Wang, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China. Tel.: +86 20 81887233; Fax: +86 20 81874903; E-mail: [email protected].

Note: [1] These authors contributed equally to this work.

DOI: 10.3233/JAD-160075

Journal: Journal of Alzheimer's Disease, vol. 52, no. 3, pp. 829-830, 2016